Table 1 Baseline characteristics per subgroup of a total number of 1877 patients.
| Closed ASD | Open ASD | Closed VSD | Open VSD | Cyan non‐Eis | Eis other | |||
|---|---|---|---|---|---|---|---|---|
| Eisenmenger's syndrome | Eisenmenger's syndrome | |||||||
| No | Yes | No | Yes | |||||
| n | 377 | 504 | 15 | 275 | 352 | 83 | 138 | 133 |
| Median (Q1–Q3) age (years) | 38 (24–50) | 40 (26–54) | 44 (34–57) | 27 (21–35) | 27 (20–36) | 30 (24–39) | 28 (22–35) | 28 (23–36) |
| Females (%) | 65 | 68 | 80 | 53 | 53 | 55 | 59 | 68 |
| PAH, n (%) | 45 (12%) | 164 (33%) | 15 (100%) | 35 (13%) | 39 (11%) | 83 (100%) | 17 (12%) | 133 (100%) |
| sPAP (in PAH), median (Q1–Q3)* | 45 (42–57) | 51.5 (42–62) | 110 (92–126) | 54 (41–75) | 60 (48–88) | 106 (96–119) | 49.5 (42–59) | 104 (90–120) |
ASD, atrial septal defect; Cyan non‐Eis, Cyanotic defect without Eisenmenger syndrome; Eis other, Eisenmenger's sydrome with an underlying defect other than a simple ASD or VSD; PAH, pulmonary arterial hypertension; Q1–Q3, 1st quartile–3rd quartile; sPAP, systolic pulmonary artery pressure; VSD, ventricular septal defect.
*Median systolic pulmonary artery pressures for the patients with PAH.